Rachel E. Mardjuki

469 citations
4 papers · 305 indexed · h-index 4
Topics
interferon and immune responses (3 papers)Viral Infections and Vectors (2 papers)Inflammasome and immune disorders (2 papers)
Partner nations
United States

In The Last Decade

Rachel E. Mardjuki

4 papers receiving 302 citations

Peers

Rachel E. Mardjuki
Comparison fields: 5 of 40
  • Immunology 246
  • Molecular Biology 164
  • Infectious Diseases 94
  • Public Health, Environmental and Occupational Health 44
  • Oncology 42
Replace Scott Drutman with:
Scott Drutman United States
Michael J. Ernandes United States
Binli Mao China
Edwin Widyanto Daniwijaya Indonesia
Jeffrey Shu United States
Patrice Debré France
Emi Kajita Japan
Zhimeng Wang China
Krishnan Harinivas Harshan India
Miriam Calao Australia
Rachel E. Mardjuki relative to Scott Drutman United States Scott Drutman's profile →
Citations per field
00.5×5.1×
Scott Drutman · 1×
Citations per year

Countries citing papers authored by Rachel E. Mardjuki

Since Specialization
Citations

This map shows the geographic impact of Rachel E. Mardjuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Mardjuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Mardjuki more than expected).

Fields of papers citing papers by Rachel E. Mardjuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel E. Mardjuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Mardjuki. The network helps show where Rachel E. Mardjuki may publish in the future.

Co-authorship network of co-authors of Rachel E. Mardjuki

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel E. Mardjuki. A scholar is included among the top collaborators of Rachel E. Mardjuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel E. Mardjuki. Rachel E. Mardjuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

About Rachel E. Mardjuki

Rachel E. Mardjuki is a scholar working on Immunology, Infectious Diseases and Molecular Biology, having authored 4 papers that have together received 305 indexed citations. Recurring topics across this work include interferon and immune responses (3 papers), Viral Infections and Vectors (2 papers) and Inflammasome and immune disorders (2 papers). The work is most often cited by research in Immunology (246 citations), Physiology (26 citations) and Infectious Diseases (94 citations). Rachel E. Mardjuki has collaborated with scholars based in United States. Frequent co-authors include Lingyin Li, Jacqueline A. Carozza, Volker Böhnert, Daniel Fernández, Lauren J. Lahey, Michael C. Bassik, Gaelen T. Hess, Christopher Ritchie, Merritt Maduke and Mark Smith. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026